Form 8-K Editas Medicine, Inc. For: Sep 29

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AAPL
2. PLTR
3. DOX
4. VRTX
5. CHKP
6. CRWD
7. ON
8. INSP
9. CVI
10. HNGE

Go back to Form 8-K Editas Medicine, Inc. For: Sep 29

Editas Medicine (EDIT) PT Lowered to $46 at Stifel

September 30, 2021 8:30 AM EDT

Stifel analyst Dae Gon Ha lowered the price target on Editas Medicine (NASDAQ: EDIT) to $46.00 (from $65.00) while maintaining a Hold rating.

The analyst commented, "Having digested today's BRILLIANCE data (Leber's congenital amaurosis type 10 [LCA10]) - see our take HERE - we... More

Editas Medicine (EDIT) Efficacy Raises The Bigger Question - Stifel

September 29, 2021 1:39 PM EDT

Stifel analyst Dae Gon Ha weighed in on Editas Medicine (NASDAQ: EDIT) with shares under significant pressure (-20%) as investors digest the early Ph.1/2 BRILLIANCE data for EDIT-101 in Leber's congenital amaurosis type 10 (LCA10).

Ha said what they initially perceived... More